Biotech financing
25WmEet
25WmEet
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Appendix<br />
Commercial leaders<br />
Commercial leaders are companies whose 2014 revenues were US$500 million or more.<br />
United States<br />
Alexion Pharmaceuticals<br />
Amgen<br />
Biogen Idec<br />
BioMarin Pharmaceutical<br />
Bio-Rad Laboratories<br />
Celgene<br />
Cubist Pharmaceuticals<br />
Gilead Sciences<br />
IDEXX Laboratories<br />
Europe<br />
Actelion<br />
Alkermes<br />
Eurofins Scientific<br />
Ipsen<br />
Jazz Pharmaceuticals<br />
Meda<br />
Novozymes<br />
QIAGEN<br />
Shire<br />
Illumina<br />
Incyte Corporation<br />
Medivation<br />
Myriad Genetics<br />
Pharmacyclics<br />
Regeneron Pharmaceuticals<br />
Salix Pharmaceuticals<br />
The Medicines Company<br />
United Therapeutics<br />
Vertex Pharmaceuticals<br />
28 Beyond borders 2016 — <strong>Biotech</strong> <strong>financing</strong>
Change language